Geraniin inhibits oral cancer cell migration by suppressing matrix metalloproteinase‐2 activation through the FAK/Src and ERK pathways

2019 ◽  
Vol 34 (10) ◽  
pp. 1085-1093 ◽  
Author(s):  
Chia‐Ming Yeh ◽  
Ming‐Ju Hsieh ◽  
Jia‐Sin Yang ◽  
Shun‐Fa Yang ◽  
Yi‐Ting Chuang ◽  
...  
Oncotarget ◽  
2016 ◽  
Vol 7 (16) ◽  
pp. 21952-21967 ◽  
Author(s):  
Chia-Ming Yeh ◽  
Chiao-Wen Lin ◽  
Jia-Sin Yang ◽  
Wei-En Yang ◽  
Shih-Chi Su ◽  
...  

Biomolecules ◽  
2020 ◽  
Vol 10 (4) ◽  
pp. 502 ◽  
Author(s):  
Bharath Kumar Velmurugan ◽  
Jen-Tsun Lin ◽  
B. Mahalakshmi ◽  
Yi-Ching Chuang ◽  
Chia-Chieh Lin ◽  
...  

Oral squamous cell carcinoma is the sixth most common type of cancer globally, which is associated with high rates of cancer-related deaths. Metastasis to distant organs is the main reason behind worst prognostic outcome of oral cancer. In the present study, we aimed at evaluating the effects of a natural plant flavonoid, luteolin-7-O-glucoside, on oral cancer cell migration and invasion. The study findings showed that in addition to preventing cell proliferation, luteolin-7-O-glucoside caused a significant reduction in oral cancer cell migration and invasion. Mechanistically, luteolin-7-O-glucoside caused a reduction in cancer metastasis by reducing p38 phosphorylation and downregulating matrix metalloproteinase (MMP)-2 expression. Using a p38 inhibitor, SB203580, we proved that luteolin-7-O-glucoside exerts anti-migratory effects by suppressing p38-mediated increased expression of MMP-2. This is the first study to demonstrate the luteolin-7-O-glucoside inhibits cell migration and invasion by regulating MMP-2 expression and extracellular signal-regulated kinase pathway in human oral cancer cell. The study identifies luteolin-7-O-glucoside as a potential anti-cancer candidate that can be utilized clinically for improving oral cancer prognosis.


2012 ◽  
Vol 2012 ◽  
pp. 1-10 ◽  
Author(s):  
Chih-Yu Peng ◽  
Hui-Wen Yang ◽  
Yin-Hung Chu ◽  
Yu-Chao Chang ◽  
Ming-Ju Hsieh ◽  
...  

Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0 μM to 40 μM). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis.


2013 ◽  
Vol 288 (28) ◽  
pp. 20217-20227 ◽  
Author(s):  
Gangli Liu ◽  
Pritam K. Sengupta ◽  
Basem Jamal ◽  
Hsiao-Ying Yang ◽  
Meghan P. Bouchie ◽  
...  

Oncotarget ◽  
2018 ◽  
Vol 9 (25) ◽  
pp. 17564-17575 ◽  
Author(s):  
Chang-Tai Chen ◽  
Ming-Ju Hsieh ◽  
Yi-Hsien Hsieh ◽  
Min-Chieh Hsin ◽  
Yi-Ting Chuang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document